Smith & Nephew plc (LON:SN) Receives GBX 1,293.33 Average PT from Analysts

Shares of Smith & Nephew plc (LON:SN) have been assigned an average recommendation of “Hold” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is GBX 1,293.33.

A number of analysts have issued reports on SN shares. Shore Capital Group reissued a “buy” rating and issued a GBX 1,000 target price on shares of Smith & Nephew in a research report on Tuesday, July 21st. Berenberg Bank dropped their price objective on Smith & Nephew from GBX 1,300 to GBX 1,250 and set a “hold” rating for the company in a research note on Friday, August 14th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,500 price objective on shares of Smith & Nephew in a report on Friday, September 4th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 1,250 target price on shares of Smith & Nephew in a research note on Tuesday, September 15th. Finally, Royal Bank Of Canada lowered their target price on Smith & Nephew from GBX 1,350 to GBX 1,250 and set a “sector perform” rating for the company in a report on Thursday, August 6th.

Smith & Nephew Stock Performance

Shares of SN stock opened at GBX 1,030.50 on Wednesday. The business has a 50 day moving average of GBX 1,094.05 and a 200 day moving average of GBX 1,142.57. The company has a debt-to-equity ratio of 73.07, a quick ratio of 0.84 and a current ratio of 2.14. The firm has a market cap of £11.30 billion, a price-to-earnings ratio of 37.10, a P/E/G ratio of 0.46 and a beta of 0.69.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.